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Abstract. The goals of this study were to facilitate sparing of the major
salivary glands while adequately treating tumor targets in patients requir-
ing comprehensive bilateral neck irradiation (RT), and to assess the po-
tential for improved xerostomia. Since 1994 techniques of target irradia-
tion and locoregional tumor control with conformal and intensity
modulated radiation therapy (IMRT) have been developed. In patients
treated with these modalities, the salivary flow rates before and periodi-
cally after RT have been measured selectively from each major salivary
gland and the residual flows correlated with glands’ dose volume histo-
grams (DVHs). In addition, subjective xerostomia questionnaires have
been developed and validated. The pattern of locoregional recurrence has
been examined from computed tomography (CT) scans at the time of re-
currence, transferring the recurrence volumes to the planning CT scans,
and regenerating the dose distributions at the recurrence sites. Treatment
plans for target coverage and dose homogeneity using static, multisegmen-
tal IMRT were found to be significantly better than standard RT plans. In
addition, significant parotid gland sparing was achieved in the conformal
plans. The relationships among dose, irradiated volume, and the residual
saliva flow rates from the parotid glands were characterized by dose and
volume thresholds. A mean radiation dose of 26 Gy was found to be the
threshold for preserved stimulated saliva flow. Xerostomia questionnaire
scores suggested that xerostomia was significantly reduced in patients ir-
radiated with bilateral neck, parotid-sparing RT, compared to patients
with similar tumors treated with standard RT. Examination of locore-
gional tumor recurrence patterns revealed that the large majority of recur-
rences occurred inside targets, in areas that had been judged to be at high
risk and that had received RT doses according to the perceived risk. Tan-
gible gains in salivary gland sparing and target coverage are being
achieved, and an improvement in some measures of quality of life is sug-
gested by our findings. Additional reduction of xerostomia may be achieved
by further sparing of the salivary glands and the non-involved oral cavity. A
mean parotid gland dose of ≤ 26 Gy should be a planning objective if sig-
nificant parotid function preservation is desired. The pattern of recurrence
suggests that careful escalation of the dose to areas judged to be at highest
risk may improve tumor control.
The underlying goal in the development of conformal and static
multisegmental intensity modulation (IMRT) techniques is to im-
prove the ratio of target to normal tissue dose, and thereby to in-
crease the probability of uncomplicated locoregional tumor con-
trol. In the treatment of head and neck cancer, we have made
efforts to use these techniques to spare the major salivary glands
while improving target irradiation.
The major salivary glands (parotid, submandibular, and sublin-
gual) produce about 90% of the salivary secretions, and the minor
salivary glands produce the remainder [1]. Of the major glands, the
parotid glands contribute the most saliva during stimulation (e.g.,
eating or drinking). Standard radiation for advanced extracranial
head and neck tumors typically involves administering radiation to
the major salivary glands bilaterally. In most cases this causes a
marked reduction in saliva output. Permanent xerostomia is the
most prevalent late side effect of irradiation for head and neck ma-
lignancies and is cited by patients as a major cause of decreased
quality of life [2–4]. In addition to its effects on subjective well-
being, decreased saliva output causes alterations in speech and
taste and difficulties with mastication and deglutition that create
secondary nutritional deficiencies. Oral mucosal dryness creates a
predisposition to fissures and ulcerations, and changes in the com-
position of the oral flora lead to dental caries and infections [5].
The treatment of radiation-induced salivary gland dysfunction
and xerostomia has been unsatisfactory. Saliva substitutes are gen-
erally ineffective. Patients who have residual salivary function may
benefit from stimulation of the glands by pilocarpine. but the se-
quelae from chronic use of this cholinergic agent may limit its use-
fulness [6]. The use of the radiation protector amifostine has been
reported to result in salivary function improvement over time [7], and
to have a significant protective effect on the salivary glands [8]. It re-
quires intravenous (IV) drug infusions before each radiation fraction,
increasing the cost and the logistic complexity of treatment.
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Since 1994, efforts at the University of Michigan to decrease xe-
rostomia have concentrated on the use of conformal irradiation
techniques to spare major salivary tissue. The ultimate goal of these
efforts has been to achieve a significant improvement in patients’
quality of life while adequately irradiating the targets.
Patients and Methods
The patients included in our studies of conformal radiotherapy
(RT) and IMRT required comprehensive, bilateral neck irradia-
tion. Had standard irradiation techniques been used in these pa-
tients, it would have encompassed most of both parotid glands
within the radiation fields. Patients with oropharyngeal, hypopha-
ryngeal, and oral cavity cancer, and patients with laryngeal cancer
and clinical evidence of neck lymph node metastases were in-
cluded.
Reliable immobilization of the head, neck, and shoulders be-
comes an essential component of planning and treatment, as pa-
tient set-up errors could lead to significant decreases in target dose
and normal tissue sparing. To permit accurate set-up while permit-
ting treatment access from most angles, an immobilization system
has been developed, consisting of a custom thermoplastic mask at-
tached to a foam cradle shaped to the patient’s back and shoulders
[9]. This system is used in our department for immobilization dur-
ing the planning computed tomography (CT) scan and during
treatment.
Magnetic resonance imaging (MRI) is performed without an im-
mobilization system, and its images are registered with the planning
CT images according to previously published methods [10]. Except
for tumors near the base of skull, there is no clear evidence suggest-
ing an additional benefit of MRI over CT in the determination of
nodal involvement or tumor extent in the extracranial head and
neck [11]. We therefore do not use MRI routinely in other tumor
locations.
An accurate selection of the targets to be irradiated, especially
targets that require elective treatment, and an accurate radio-
graphic delineation of the extent of disease are critical steps in the
planning of conformal RT. The targets are defined as “primary,”
including the primary tumor and lymph nodes with clinical or ra-
diographic evidence of metastases, and “secondary,” consisting of
lymph node groups that are at risk of harboring subclinical metas-
tases. Our choices of lymph node targets and the methods of their
delineation on the axial planning CT images have been described
elsewhere [12]. Of note, in the neck judged to be at lower risk (con-
tralateral to the primary tumor and without clinical evidence of
metastatic disease), the most cranial nodal group defined for adju-
vant treatment is the jugulodigastric nodal group (extending crani-
ally to the axial CT image in which the posterior belly of the digas-
tric muscle crosses the jugular vein). In the neck at higher risk in the
same patient (ipsilateral to the primary tumor or the neck contain-
ing clinically apparent metastases) the cranial-most jugular nodes
are outlined up to the base of the skull in the poststyloid area. These
adjuvant target definitions facilitated substantial parotid gland
sparing in the neck at lower risk of metastases and were anticipated
not to compromise tumor control, as most contralateral neck me-
tastases are found in the jugulodigastric nodes [13].
Patients with nasopharyngeal cancer or patients with clinically
apparent bilateral neck metastases require treatment of the jugular
nodal chain through the base of skull bilaterally. In patients with
oropharyngeal, hypopharyngeal, and nasopharyngeal cancer, the
retropharyngeal nodes are defined as targets bilaterally.
The extent of subclinical disease in the vicinity of the gross tumor
in each case is unknown. We therefore typically expand the gross
target volume (GTV) of the primary tumor and lymph node metas-
tases by 1 to 2 cm, depending on the perceived risk at each site, to
yield the clinical target volume (CTV), which accounts for micro-
scopic tumor extension. Nodal groups at risk are also defined as
CTVs. Three-dimensional expansions of the CTVs, to yield plan-
ning target volumes (PTVs), are made automatically by the plan-
ning system. In addition to the targets, noninvolved structures rel-
evant to planning are outlined on the axial CT images, including the
parotid, submandibular, and sublingual glands, as well as the laryn-
geal glottis, the spinal cord, and the oral cavity, to facilitate sparing
and to assess the doses delivered to these structures.
Our methods for parotid gland sparing have evolved over time.
Initially, a modification of the standard 3-field radiation technique
was employed, using beam’s eye view (BEV) displays of the targets
and the major salivary glands to choose beam angles that would
assure target coverage and spare parotid gland tissue [12]. Since
1996, IMRT has been used [14]. This method makes use of fixed
field shaping to create intensity-modulated fields by adding the
dose from several different-shaped segments delivered in the same
direction. The development and detailed description of a typical
plan have been published elsewhere [15]. The spinal cord maximal
dose is constrained at 50 Gy. This is a DVH-derived dose that in-
cludes all direct, scattered, and transmitted radiation. We have pre-
viously found that this dose in a three -dimensional conformal plan
is comparable to the dose delivered to the spinal cord from stan-
dard opposed lateral fields that are blocked off-cord at 45 Gy [16].
Planning has until recently been a forward, iterative process. Re-
cently, an automated optimization approach has been developed in
our department [14]. It involves the use of “costlets” (individual
components of the cost function) to describe the behavior of indi-
vidual features of the desired solution [17] and the use of “beam-
lets” (distinct segments or a variable size grid of squares) to allow
optimization based on dose distribution [18].
Measurements of salivary flow rate from each major gland are
made before and periodically after radiation to verify the extent of
functional sparing and to assess dose–volume–effect relationships.
Unstimulated and stimulated saliva is collected from each parotid
gland in a collecting cup placed over the orifice of the parotid
(Stensen’s) duct as described previously [19]. Repeated pre-RT sa-
liva flow rate measurements found high inter-observer and intra-
observer correlation coefficients [20].
The ultimate goal of these efforts to spare the salivary glands is to
improve the quality of life for our patients. To this end, we have
used several tools to assess xerostomia-related and general quality-
of-life issues in patients treated with parotid-sparing techniques.
The initial tool consisted of a panel of five questions that had been
found by other investigators to correlate with objective salivary hy-
pofunction [21]. As the study progressed it became apparent that
this tool was not sensitive enough to detect subtle differences in
xerostomia, so additional tools were developed. A questionnaire
was developed from a previously published questionnaire [22] that
was modified after our experience with patient symptoms. It con-
sists of eight questions to which the answers are given in a numeric
scale ranging from 0 (no dryness) to 10 (severe dryness). The ques-
tions probe the patients’ rating of mouth dryness while not eating;
dryness leading to problems with chewing, swallowing food, sleep-
ing, and talking; discomfort of dentures; frequency of use of oral
comfort aids; and frequency of fluid intake to aid eating. Tests of
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the reliability and validity of this tool were found to be satisfactory.
In addition to the xerostomia-specific questionnaires, general qual-
ity of life is assessed by means of a validated tool developed at the
University of Michigan that contains questions about the domains
of pain, communication, eating, and emotions [23].
A crucial concern in this work is whether conformal and IMRT
techniques, aimed at delivering radiation selectively to defined tar-
gets, compromise tumor control compared with standard radiation.
To gain accurate data about the locoregional recurrence pattern
and the doses delivered to the sites of recurrence, diagnostic CT
scans were performed when recurrences occurred. The recurrent
tumor volume was defined on the CT and transferred to the pre-
treatment CT data set used for radiation planning. The dose of ra-
diation received by the volume of recurrence during RT could then
be calculated and analyzed. Recurrences were categorized as being
inside, at the margins, or outside the original target volumes (“in
field” if 95% or more of the recurrence volume was encompassed
by the full prescribed dose, “marginal” if 20% to 95% of the volume
was encompassed, and “outside” if less than 20% of the recurrence
volume lay within the full dose).
Results
The adequacy of target coverage by the multisegmental intensity
modulation plans was assessed. Fifteen patients with stage III/IV
head and neck cancer requiring comprehensive, bilateral neck ir-
radiation were planned and treated with the IMRT techniques de-
scribed above. For purposes of comparison, standard radiation
fields were devised retrospectively for each patient, with the same
CT-derived targets used for the IMRT plans [15]. On average, the
minimal dose to the primary target volume in the conformal plans
was significantly higher than that in the standard plans (95% versus
91%; p = 0.02). Similar advantages of the conformal plans were
found in the coverage of the jugular nodes. In the conformal plans,
the magnitude and volumes of high doses in noninvolved tissue
were significantly reduced. The mean doses to all major salivary
glands, most notably the contralateral parotid (receiving on aver-
age 32% of the prescribed dose) were significantly lower in the con-
formal plans than they would have been with standard radiation
plans. The mean dose to the noninvolved oral cavity also tended to
be lower in the conformal plans (p = 0.07) [15].
The relationships between the three-dimensional dose distribu-
tions and the salivary output from parotid glands were recently ex-
amined [24]. Unstimulated and stimulated saliva flow rates from
parotid glands of 88 patients were measured before RT and at 1, 3,
6, and 12 months after the completion of RT. Glands receiving a
mean dose below or equal to threshold (24 Gy for the unstimulated
and 26 Gy for the stimulated saliva) showed substantial preserva-
tion of the flow rates after RT, and salivary flow continued to im-
prove over time (to median 76% and 114% of the pre-RT rates for
the unstimulated and stimulated flow rates, respectively, at 12
months). In contrast, most glands receiving a mean dose higher
than the threshold produced little saliva and showed no recovery
over time. Similarly, partial volume thresholds were found: 67%,
45%, and 24% gland volumes receiving more than 15 Gy, 30 Gy,
and 45 Gy, respectively. Diminished salivary flow was observed in
glands receiving each specified dose to a partial volume larger than
the threshold.
To achieve bilateral parotid gland sparing treatment plans that
meet our recently defined constraints arising from the saliva flow
study (mean dose  26 Gy), investigations have begun that use the
automated optimization system developed in our department..
Treatment plans employ beams that are divided into a grid of 1 × 1
cm “beamlets,” each delivering an optimized dose intensity de-
pending on whether targets or noninvolved tissues are in its path
(Figs. 1 and 2). Preliminary results show that a plan consisting of
three coplanar beams and an additional noncoplanar, anterior-
inferior beam, produce dose distributions that cover the targets ad-
equately and satisfy the dose constraints for the spinal cord and oral
cavity in many patients. Such a plan also satisfies the dose con-
straints for both parotid glands (Fig. 3).
Fig. 1. “Beamlet” array (1 × 1 cm grid) in a lateral field. The beamlet dose
intensities are superimposed on the targets and normal structures (parotid
gland, oral cavity, and spinal cord).
Fig. 2. An arrangement of three axial fields and an anterior-inferior field
in the treatment planning for a patient with oropharyngeal cancer. Each
field is composed of beamlets similar to the example shown in Figure 1.
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Subjective xerostomia scores using the eight-question validated
questionnaire (described in Patients and Methods) were compared
in a preliminary, nonrandomized study among groups of 17 pa-
tients who received bilateral neck, parotid-sparing RT at the Uni-
versity of Michigan (group 1), 13 similar patients who received
standard RT in affiliated facilities (group 2), and 19 patients with
smaller tumors who received unilateral neck RT (group 3) [25].
One year after the completion of RT, the mean xerostomia scores
(± S.D.) were 33 ± 15, 49 ± 13, and 15 ± 14, for groups 1, 2, and 3,
respectively (a higher score meaning worse xerostomia). The scores
of patients receiving bilateral neck, parotid-sparing RT were sig-
nificantly lower than the scores of patients receiving standard RT
(p = 0.005). The scores of patients receiving unilateral neck RT
were significantly lower than either group receiving bilateral neck
RT. A simple relationship between the saliva output from the ma-
jor salivary glands and the xerostomia scores was not found.
The pattern of locoregional tumor recurrenceafter comprehen-
sive, parotid-sparing RT, was recently examined in all 58 patients
treated in our department between April 1994 and June 1998. At a
median follow-up of 27 months in patients who were still alive
(range, 6 to 60 months), locoregional recurrences were observed in
12 (21%): local in 3, regional in 7, and synchronous local and re-
gional in 2. Four of the regional recurrences occurred in the para-
pharyngeal and retropharyngeal nodal areas near the base of skull,
ipsilateral to the primary tumor in patients with oral and oropha-
ryngeal primary tumors. Three of the recurrences near the base of
skull were in-field, in areas that had received the prescribed dose
for subclinical disease (50–60 Gy), and one was a marginal recur-
rence. Overall, 10 of the 12 recurrences were in-field, in areas
judged to be at high risk, and 2 were marginal recurrences. No re-
currences were observed in the parapharyngeal areas near the base
of the skull contralateral to the primary tumor, areas that were
spared during RT planning.
Discussion
The results of our studies of saliva flow versus dose and volume of
irradiated parotid glands based on DVHs suggest that dose–
volume-function relationships are characterized by dose and vol-
ume thresholds, and by steep dose–response relationships when
the thresholds have been reached. A parotid gland mean dose of 26
Gy was found to be a threshold for the stimulated saliva flow. This
mean dose serves now as a planning objective for the parotid
glands. Similar dose thresholds have been found by other investi-
gators using standard RT [26], and higher doses were found by oth-
ers [27, 28]. Previous attempts to relate dose and effect relation-
ships in the salivary glands relied on estimations of the dose and
irradiated gland volumes based on the simulation films, estimations
that are fraught with uncertainty. Also, the use of standard RT in
the previous studies (usually lateral opposed beams) limited the
range of RT doses and irradiated gland volumes, diminishing the
investigators’ ability to assess dose–response relationships over a
wide range of doses and irradiated gland volumes.
Preliminary results of xerostomia-related quality-of-life studies
suggest a significant improvement in patients treated with parotid-
sparing techniques compared with patients with similar cancer re-
ceiving standard RT. Our results, however, also showed that pa-
tients receiving unilateral neck RT fared better, in terms of their
symptoms, than patients receiving parotid-sparing bilateral neck
RT. These findings suggest that further improvements in major
salivary gland and oral cavity sparing can be expected to result in
still better quality-of-life measures.
Of the issues we have encountered and described in this article,
the choice and adequate radiologic definition of the targets are ar-
guably the most perplexing and important. It has previously been
shown that definition of head and neck nodal volumes varies sig-
nificantly among different experienced radiologists [29, 30]. The
need for adequate anatomic definitions of the targets is a prereq-
uisite for accurate conformal RT planning and for adequate tumor
control. Steps toward accurate and reproducible descriptions of ra-
diologic target definitions in the head and neck for radiation plan-
ning have recently been made [31, 32]. Insight into this issue may be
gained from a careful analysis of the pattern of recurrences relative
to the targets outlined and the doses received during treatment. In
our study, the large majority of recurrences thus far have occurred
in-field, in areas judged to be at high risk, having received the full
prescribed dose. This pattern is similar to the pattern of locore-
gional recurrence observed after standard, three-field RT [33].
This finding highlights the possibility that carefully designed dose
escalation to the highest risk targets, using conformal techniques
with tight dose margins, may improve tumor control without in-
creasing complications. The most important question surrounds
the rates of tumor control after IMRT compared to the rates ob-
served after standard RT. The answer can only be given by large,
randomized, multi-institutional studies. Such trials are required to
assess the extent to which these new, labor-intensive and costly
techniques serve to improve quality of life while preserving or im-
proving tumor control rates beyond the results achieved with stan-
dard radiation.
Résumé. Le but de cette étude a été, chez les patients nécessitant une
radiothérapie bilatérale du cou (RT), de développer des techniques
facilitant la conservation des glandes salivaires majeures tout en traitant
de façon efficace les cibles souhaitées et également, d’évaluer la possibilité
de reduire la fréquence de xérostome et d’améliorer l’irradiation au niveau
de la cible et ainsi le contrôle locorégional de la tumeur. Des techniques
Fig. 3. Dose–volume histograms of the targets and uninvolved structures.
The prescribed doses are 70 Gy to the primary tumor and 50 Gy to the nodal
targets. Beam arrangement is described in Figures 1 and 2. 1: spinal cord; 2:
left parotid; 3: right parotid; 4: uninvolved oral cavity; 5: left jugular nodes
planning target volume (PTV); 6: right jugular nodes PTV; 7: retropharyn-
geal nodes PTV; 8: primary tumor PTV.
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conformes comportant avec modulation d’intensité (IMRT) ont été
développés depuis 1994. Chez les patients traités ainsi, on a mesuré
sélectivement, les débits avant et, de façon périodique, après RT, à partir de
chaque glande salivaire majeure. Les débits résiduels ont ensuite été
corrélés avec les histogrammes dose/volume (DVHs). Un questionnaire
subjectif sur la xérostome a été développé et validé. La topographie des
récidives locorégionales a été évaluée par tomodensitométrie au moment de
la récidive, avec transfert des volumes de récidives pour adapter et
redistribuer les doses au niveau des sites des récidives. La couverture des
cibles et l’homogénéité des doses délivrées ont été améliorées par le
traitement par IMRT multisegmentaire poar rapport aux plans de coupes
standard de RT. La conservation de la glande parotide a été
significativement augmentée dans les plans dits de conformité. Les
rapports entre les doses, le volume irradié et les débits résiduels de salive
des glandes parotides ont été caractérisées par des valeurs seuils de dose et
de volume. La valeur seuil pour conserver un débit salivaire stimulé. Les
scores du questionnaire de xérostome ont suggéré que la fréquence de
xérostome a été significativement réduite chez les patients traités par une
RT cervicale bilatérale visant à conserver la parotide, comparé aux
patients porteurs de tumeurs similaires traités par une RT standard.
L’analyse de la topographie des récidives tumorales loco-régionales a
montré que la plupart des récidives se sont produites à l’intérieur des
cibles, dans les régions estimées être à haut risque et qui ont été irradiées
selon le risque perçu. On a pu ainsi obtenir un gain considérable en ce qui
concerne la conservation glandulaire et la couverture des cibles. Nos
données suggèrent une amélioration de la qualité de vie selon certains
critères: réduction supplémentaire de la fréquence de xérostomes,
conservation des glandes salivaires et de la cavité buccale saine. Il faut
donc envisager une dose moyenne de 26 Gy ou moins sur la glande parotide
pour pouvoir espérer une conservation de la fonction de la parotide. La
topographie des récidives suggère qu’une augmentation soigneuse des
doses dans les régions estimées être à risque élevé pourrait améliorer le
contrôle tumoral.
Resumen. El propósito del presente estudio es desarrollar una técnica que
facilite preservar las glándulas salivares principales al tiempo que se
traten los volúmenes blanco (targets) en pacientes que requieran
irradiación bilateral comprensiva (RT), y evaluar el potencial de mejorı́a
de la xerostomia, la irradiación del volumen blanco y el control
local-regional del tumor. A partir de 1994 se han desarrollado técnicas
conformales y de intensidad modulada (TCIM). En los pacientes ası́
tratados se hizo la medición selectiva de las tasas de flujo salivar de cada
glándula antes de la RT y periódicamente luego de completar la RT, para
correlacionar los flujos residuales con los histogramas de volumen-dosis.
Se desarrollaron y valoraron cuestionarios de xerostomia. Se estudió el
patrón de las recurrencias locales-regionales por medio de TAC en el
momento de la recurrencia, para transferir los volúmenes de la recurrencia
a los TACS de simulación y para regenerar ası́ la distribución de la dosis en
los lugares de la recurrencia. Tanto el cubrimiento del volumen blanco
como la homogeneidad en los planes de tratamiento utilizando TCIM
multisegmentario estático resultaron significativamente mejores que los
planes de RT estándar. Además, con los planes conformales se logró una
significante preservación de la glándula parótida. La relación entre dosis,
volumen irradiado y las tasas de flujo salivar residual de las glándulas
parótidas se caracterizaron por los umbrales de dosis y volumen. Se
encontró que una dosis promedio de 26 Gy era el umbral para preservar el
flujo salivar estimulado. Los resultados del cuestionario de xerostomia
sugieren que la xerostomia se redujo en forma significante en los pacientes
que recibieron RT bilateral con preservación de la parótida, en
comparación con pacientes con tumores similares tratados con RT
estándar. El análisis de los patrones de recurrencia tumoral local regional
reveló que la gran mayorı́a de las recurrencias ocurrió dentro de las áreas
de volumen blanco, en zonas que habı́an sido consideradas como de alto
riesgo y que habı́an recibido dosis de RT según la percepción del riesgo.
Progresos tangibles han sido logrados en cuanto a la preservación de las
glándulas salivares y de cobertura del área de volumen blanco, al tiempo
con una mejorı́a en la calidad de vida, a juzgar por nuestros hallazgos. Se
puede lograr una reducción adicional de la xerostomia mediante mayor
preservación de las glándulas salivares y de las regiones no afectadas de la
cavidad oral. Una dosis promedio de ≤26 Gy debe ser el objetivo de la
planeación si se pretende conservar una función parotı́dea significante. El
patrón de recurrencia sugiere que la cuidadosa escalada de la dosis en
áreas que se consideren de alto riesgo puede mejorar el control tumoral.
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